Sikjær Melina Gade, Hilberg Ole, Fløe Andreas, Dollerup Jens, Løkke Anders
Department of Respiratory Medicine and Allergology, Aarhus University Hospital, Aarhus C, Denmark.
Senior Scientific Advisor, GSK, Brøndby, Denmark.
Eur Clin Respir J. 2018 Aug 14;5(1):1506235. doi: 10.1080/20018525.2018.1506235. eCollection 2018.
: Although chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality globally, several studies have shown little awareness of COPD in the general population. The awareness of COPD in the Scandinavian countries is, however, sparsely investigated. : The aim of this study was to explore the awareness in the general Danish population of smoking-related health risks and symptoms related to COPD and attitudinal factors concerning smoking. : Adults aged 18 years or older were randomly selected to reflect the background population. An Internet-based questionnaire was conducted in January-February 2015. : A total of 1002 answered the questionnaire (515 males; 487 females). In total, 17.7% were current smokers (men: 15.5%-women: 19.9%). More smokers and ex-smokers knew the symptoms of COPD compared to never-smokers ( < 0.001). Ex-smokers had undergone more pulmonary function tests than smokers and never-smokers ( < 0.001) and significantly more men than women who had undergone pulmonary function test. Ex-smokers were more likely to rate cancer as the most feared disease ( = 0.026) than the smokers. Of the smokers, 28% did not regard COPD as a deadly disease and significantly more smokers than ex-/never-smokers believed that smoking cessation should not be mandatory before treatment of COPD and asthma ( < 0.001). : Overall, smokers, ex-, and never-smokers had little knowledge of COPD regarding aetiology, symptoms, and severity thus emphasizing the necessity of early detection of COPD and more focus on spirometry in general practice, especially amongst smokers. There is a great discrepancy between the attitude of smokers and ex-/never-smokers towards mandatory smoking cessation before receiving treatment of smoking-related diseases. : GlaxoSmithKline Pharma A/S Brøndby, financially supported the collecting of data by Voxmeter A/S. The authors had full access to the raw data and did not receive any financially support.
尽管慢性阻塞性肺疾病（COPD）是全球发病和死亡的主要原因之一，但多项研究表明，普通人群对COPD的认知程度很低。然而，斯堪的纳维亚国家对COPD的认知情况鲜有人研究。
本研究的目的是探讨丹麦普通人群对吸烟相关健康风险、COPD相关症状以及吸烟态度因素的认知情况。
随机选取18岁及以上成年人以反映总体人群情况。2015年1月至2月进行了一项基于互联网的问卷调查。
共有1002人回答了问卷（515名男性；487名女性）。总体而言，17.7%为当前吸烟者（男性：15.5%，女性：19.9%）。与从不吸烟者相比，更多的吸烟者和曾经吸烟者了解COPD的症状（P<0.001）。曾经吸烟者接受肺功能测试的次数多于吸烟者和从不吸烟者（P<0.001），且接受肺功能测试的男性明显多于女性。曾经吸烟者比吸烟者更有可能将癌症列为最恐惧的疾病（P=0.026）。在吸烟者中，28%不认为COPD是致命疾病，且吸烟者比曾经/从不吸烟者更坚信在治疗COPD和哮喘之前不应强制戒烟（P<0.001）。
总体而言，吸烟者、曾经吸烟者和从不吸烟者对COPD的病因、症状和严重程度了解甚少，因此强调了在全科医疗中早期发现COPD以及更加关注肺活量测定的必要性，尤其是在吸烟者中。吸烟者与曾经/从不吸烟者在接受吸烟相关疾病治疗前对强制戒烟的态度存在很大差异。
葛兰素史克制药公司（丹麦布隆德比）资助了Voxmeter公司收集数据。作者可以完全获取原始数据，且未接受任何资金支持。
